意大利 - 意大利文 - AIFA (Agenzia Italiana del Farmaco)

nuova farmec s.r.l. - iodopovidone - iodopovidone

瑞士 - 意大利文 - Swissmedic (Swiss Agency for Therapeutic Products)

bavarian nordic berna gmbh - salmonella typhi viva stamm ty 21a - capsule - salmonella typhi viva stamm ty 21a min.2 mia. u., salmonella typhi inactivata stamm ty 21a, saccharum 7.9-44 mg, e 300, caseinum hydrolysatum, magnesii stearas, lactosum max. 176.4 mg, kapselhülle: gelatina, e 171, e 127, e 172 (flavum), e 172 (rubrum), Überzug: hypromellosi phthalas, diethylis phthalas, ethylenglycolum, pro capsula. - immunizzazione attiva contro il tifo abdominalis, a partire dai 5. anni - vaccini

瑞士 - 意大利文 - Swissmedic (Swiss Agency for Therapeutic Products)

jntl consumer health ii (switzerland) gmbh - domperidonum - compresse rivestite con film - domperidonum 10 mg, lactosum monohydricum 54.2 mg, maydis amylum, cellulosum microcristallinum, amyla, povidonum k 90, magnesii stearas, gossypii oleum hydrogenatum, hypromellosum, natrii laurilsulfas corresp. natrium 0.02 mg, pro compresso obducto. - nausea e vomito - synthetika

瑞士 - 意大利文 - Swissmedic (Swiss Agency for Therapeutic Products)

janssen-cilag ag - domperidonum - sospensione - domperidonum 1 mg, sorbitolum liquidum non cristallisabile corresp. sorbitolum 318.5 mg, cellulosum microcristallinum et carmellosum natricum, e 218 1.8 mg, propylis parahydroxybenzoas 0.2 mg, polysorbatum 20, natrii hydroxidum, saccharinum natricum aqua purificata ad suspensionem pro 1 ml corresp. natrium 0.11 mg. - nausea e vomito - synthetika

瑞士 - 意大利文 - Swissmedic (Swiss Agency for Therapeutic Products)

jntl consumer health ii (switzerland) gmbh - domperidonum - compresse orodispersibili - domperidonum 10 mg, gelatina, mannitolum, poloxamerum 188, aromatica (minz-aroma) cum alcohol benzylicus 3.8 µg et ethanolum 0.03 µg, aspartamum 750 µg, pro compresso. - nausea e vomito - synthetika

瑞士 - 意大利文 - Swissmedic (Swiss Agency for Therapeutic Products)

jntl consumer health ii (switzerland) gmbh - domperidonum - compresse orodispersibili - domperidonum 10 mg, gelatina, mannitolum, poloxamerum 188, aromatica (minz-aroma) cum alcohol benzylicus 3.8 µg et ethanolum 0.03 µg, aspartamum 750 µg, pro compresso. - nausea e vomito - synthetika

意大利 - 意大利文 - AIFA (Agenzia Italiana del Farmaco)

boehringer ingelheim italia s.p.a. - brotizolam - brotizolam

瑞士 - 意大利文 - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - nilotinibum - capsule - nilotinibum 200 mg ut nilotinibi hydrochloridum monohydricum, lactosum monohydricum 156.11 mg, crospovidonum, poloxamerum 188, silica colloidalis anhydrica, magnesii stearas, kapselhülle: gelatina, e 171, e 172 (flavum), drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, e 172 (rubrum), pro capsula. - trattamento della leucemia mieloide cronica - synthetika

瑞士 - 意大利文 - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - nilotinibum - capsule - nilotinibum 150 mg per nilotinibi hydrochloridum monohydricum, lactosum monohydricum 117.08 mg, crospovidonum, poloxamerum 188, silice colloidalis anhydrica, magnesio stearas, kapselhülle: gelatina, e-171, e-172 (rosso) e 172 (giallo), drucktinte: lacca, e 172 (nero), propylenglycolum, ammoniae soluzione del 28 per cento, per una piccola scatola. - trattamento della leucemia mieloide cronica - synthetika

瑞士 - 意大利文 - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - nilotinibum - capsule - nilotinibum 50 mg a nilotinibi hydrochloridum monohydricum, lactosum monohydricum 39.025 mg, crospovidonum, poloxamerum, silice colloidalis anhydrica, magnesio stearas, kapselhülle: gelatina, e-171, e 172 (giallo) e 172 (rosso), drucktinte: lacca, e 172 (nero), propylenglycolum, ammoniae soluzione del 28 per cento, per una piccola scatola. - trattamento della leucemia mieloide cronica - synthetika